Concepedia
Statistics
Publications
9
Citations
323
H-Index
Active since
2016
Affiliations
Taipei City Hospital(Current)
National Yang Ming Chiao Tung University
Taipei Veterans General Hospital
Fu Jen Catholic University
Chang Bing Show Chwan Memorial Hospital
Ka-Yi Lau is an author at Taipei City Hospital specializing in oncology, triple-negative breast cancer therapy, and molecular oncology.
Publications per year
2016–2023
Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells
Chun-Yu Liu, Ka-Yi Lau, Chia‐Chi Hsu et al. · PLoS ONE · 2017 · 64 citations · Full text
Medicine, Oncology, Pharmacology +17
Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression
Chun-Yu Liu, Tzu‐Ting Huang, Yi‐Ting Chen et al. · EBioMedicine · 2019 · 53 citations · Full text
Medicine, Cancer Biology, Oncology +16
Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression
Tzu‐Ting Huang, Ling‐Ming Tseng, Ji‐Lin Chen et al. · EBioMedicine · 2020 · 42 citations · Full text
Medicine, Cancer Biology, Oncology +17
The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells
Chun‐Yu Liu, Tzu‐Ting Huang, Pei‐Yi Chu et al. · Experimental & Molecular Medicine · 2017 · 40 citations · Full text
Life Sciences, Oncology, Pharmacology +16
EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells
Chun‐Yu Liu, Tzu‐Ting Huang, Chun‐Teng Huang et al. · European Journal of Cancer · 2016 · 39 citations
Life Sciences, Oncology, Pharmacology +14
1–5 of 9